Thur., Nov. 15; noon, Fukushima Auditorium
Keith Martin, M.D., executive director of the Consortium of Universities for Global Health, will dicuss global health challenges at the WVU Health Sciences Center on Thur., Nov. 15 at noon in Fukushima Auditorium.
Dr. Martin's talk, "From West Virginia to the World: How Academia Can Impact Big Global Health Challenges," will address the state’s unique role in global health and how engagement in global health issues can serve to enhance awareness and outcomes of challenges here in Appalachia.
Dr. Martin has served in his role at the CUGH since 2012. CUGH is comprised of 170 academic institutions from around the world, and leverages the capabilities of these institutions across research, education, advocacy and service to address global challenges. CUGH is particularly focused on improving health outcomes for the global poor and strengthening academic global health programs.
This talk is open to all members of the WVU and Health Sciences communities, and complimentary box lunches will be provided for the first 50 attendees.
All Health Sciences faculty members are requested to review a proposed Board of Governors Rule currently in a 30-day comment period: WVU Governance Rule 1.4 on Ethics, Conflict of Interest, and Outside Consulting. The review period for the proposed rule closes on December 12.
West Virginia University first site to launch clinical trial utilizing non-opioid micropellet implant for chronic pain
As part of an ongoing commitment to battle opioid addiction, the Rockefeller Neuroscience Institute (RNI) at West Virginia University today (Nov. 15) marked a major milestone, enrolling the first patient in a randomized clinical trial that will test the effectiveness of an injectable non-opioid, non-steroid micropellet to treat sciatica.
WVU researchers help West Virginia become first state to collect real-time data on neonatal abstinence syndrome
As opioid use has pervaded West Virginia, the rate of infants who develop neonatal abstinence syndrome has increased. But significant barriers—including that various ways healthcare providers define NAS and document it in medical records—make it difficult for researchers to capture NAS data that is useful and reliable.